P Jonathan Li1, Sachin Shah2, Neil Mehta3

  • 1University of California San Francisco School of Medicine, 533 Parnassus Avenue, San Francisco, CA, 94143, USA. po-yi.li@ucsf.edu.

概括

肝细胞癌 (HCC) 肝移植方面的进展包括免疫疗法等新疗法和改善供体器官的可用性. 这些创新旨在克服供体短缺,并加强移植前和移植后的HCC管理.